462 results on '"Gratacós, Jordi"'
Search Results
2. Specific-cytokine associations with outcomes in knee osteoarthritis subgroups: breaking down disease heterogeneity with phenotyping
3. Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
4. Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas
5. Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease
6. Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study
7. Strategies and resources to optimise the management of Psoriatic Arthritis patients: The CREA Project
8. Recursos y estrategias para optimizar el manejo de los pacientes con artritis psoriásica: proyecto CREA
9. Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study
10. Resources and strategies for the optimal care of patients with axial spondyloarthritis: The CREA project
11. Recursos y estrategias para la óptima atención de los pacientes con espondiloartritis axial: Proyecto CREA
12. Expert recommendations for the use of apremilast in psoriatic arthritis
13. Recomendaciones de expertos para el uso de apremilast en artritis psoriásica
14. Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas
15. Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition
16. Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients
17. Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO
18. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
19. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies
20. Riesgo de infección asociado a los inhibidores de las quinasas Janus (JAK) y las terapias biológicas en enfermedad inflamatoria intestinal y artritis reumatoide. Estrategias de prevención
21. Remission in axial spondyloarthritis: Developing a consensus definition
22. Is obesity a predictor for lack of response to treatment in psoriatic arthritis? A systematic review
23. ¿Es la obesidad un factor predictivo de falta de respuesta al tratamiento en la artritis psoriásica? Actualización de una revisión sistemática
24. A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action
25. Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study
26. Rôle de l’antigène HLA-B27 dans les comorbidités observées au cours de la spondyloarthrite axiale : données du registre COMOSPA
27. Inflammatory bowel disease in axial spondyloarthritis patients. Is there any specific clinical picture? Data from the RESPONDIA and REGISPONSER registries.
28. Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA
29. Assessment of SpondyloArthritis International Society (ASAS) consensus on Spanish nomenclature for spondyloarthritis
30. Consenso ASAS en nomenclatura en español para las espondiloartritis
31. Quality standard for the management of patients with psoriatic arthritis: QUANTUM project
32. Norma de calidad para el manejo del paciente con artritis psoriásica: proyecto QUANTUM
33. Predictors of flares in recent-onset psoriatic arthritis. Results of a multivariable model based on machine learning
34. Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)
35. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project
36. Estado actual de la atención multidisciplinar para pacientes con artritis psoriásica en España: proyecto NEXUS 2.0
37. Synovial fluid but not plasma interleukin-8 is associated with clinical severity and inflammatory markers in knee osteoarthritis women with joint effusion
38. Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
39. Registro Español de Artritis Psoriásica de Reciente Comienzo (estudio REAPSER). Objetivos y metodología
40. Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study
41. Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis
42. Information Needs of Patients With Spondyloarthritis About Their Disease
43. Recomendaciones de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en espondiloartritis axial
44. Necesidades informativas de los pacientes con espondiloartritis sobre su enfermedad
45. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
46. Corrigendum: The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
47. Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries
48. Multidisciplinary Care Models for Patients With Psoriatic Arthritis
49. Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España
50. Does Belonging to a Patient Association Is of Help for Patients with Axial Spondyloarthritis? Results from the Atlas Survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.